Deepl translation without graphs of this: https://blog-gerard.maudrux.fr/2021/05/28/inde-covid-et-ivermectine-suite/
India: Covid and Ivermectin, continued.
Posted on 28 May 2021 by Gérard Maudrux
A month ago, all our “Covid specialists” and the press were rushing to India, like flies to vinegar. I had immediately taken the opposite view in a post on April 27, to explain that on the one hand their epidemiological situation (I’m not talking about their sanitary situation, which is bad, that’s another problem) was not worse than ours, on the contrary, and on the other hand I was saying that we had to wait a bit to see the result of the use of Ivermectin on a large scale, in the face of a powerful wave, of which it was said in France (as here) that the peak would not be reached for several weeks, whereas it had already passed!
Who was right? The alarmists? The defenders of Ivermectin? The result is there, resounding, indisputable. Yet not a word in the press, not a word from our specialists. No one wonders how the Indians, with fewer resources, have done ten times better than us. No one is trying to find out how to copy them or be inspired by them.
Here is the curve of new Covid cases in India, last updated on 27 May. You can see the peak of cases on the date I predicted, not after several weeks as announced, and then an extremely rapid drop. This drop is faster than their first wave, which was poorly treated, which was spread out but not as strong. And yet they have the Indian variant!
When the governments of several states began to advise, or even distribute, Ivermectin, there was an offensive by the WHO, which issued communiqués saying that it did not advise Ivermectin, and by Gilead, which sprayed the country with Remdesivir at a derisory price without the international medical community being bothered, even though it knew that this drug was ineffective and dangerous. Ivermectin had to be countered.
The result is even more obvious when we compare the states that treat and those that do not, such as Tamil Nadu, which has decided to follow the WHO guidelines.
Here are the curves in states that treat extensively with ivermectin such as Uttar Pradesh, Uttarakhand and Delhi. The former went from 37,900 cases at peak to 3,100 cases, the latter from 9,600 to 2,800 cases, the latter from 28,400 to 1,500 cases. Other states such as Maharashtra, Rajasthan and Madhya Pradesh show the same scores, which are proportional to the importance of Ivermectin use.
In contrast, Tamil Nadu, which bans the treatment, was at 11,000 cases when the others were at their peak, and is now at 35,100 cases (it seems to have reached a plateau).
Even more telling is a summary curve:
It should be noted that these results concern several hundred million inhabitants (Uttar Pardesh is 3 times the size of France), and are only obtained with early treatment, in a country where only 3% of the population has received its two doses of vaccine.
In France, on the other hand, we are pleased that our second wave has ended, “thanks to vaccination”. The comparison of the curves and the decreasing slopes is eloquent: 6 months on one side versus 1 month on the other. Peak at 56,000 cases on 3 November, for 13,933 yesterday.
These Indian curves, their media treatment 1 month ago and now, these results, illustrate the great manipulation of the French opinion about the possible treatments for Covid.
I would like to take this opportunity to thank you for your reactions to the previous post, which touched me, and I hope that they will also have touched the Ordre des Médecins and will make it reflect on its attitude towards those who try to treat their patients. I repeat, we have an obligation of means, not necessarily of success. Not to try to treat, and especially to prevent others from trying to treat is unworthy of the profession, a fault, especially on the part of those who give lessons in deontology. They should also look at what doctors elsewhere are doing, and what their results are, results they don’t seem to want here.
As for your offers of help, thank you too. I did not accept because nothing will happen for a year, and if you invest today and nothing happens for months, you will wonder. We will talk about it again when the opportunity arises.
Apparently ivermectin costs the state 10 euros for 15 kilos of the medicine. The daily dose per person depends on their weight – 0.2 milligrams per kilo. Which would, for someone weighing 80 kilos, cost the state (admittedly before packaging etc.) just 1.6 euros for 10,000 days’ supply (or, more rationally, less than half a cent for 30 days’ supply, or even more rationally – since you’re likely to recover after less than 10 days, 0.16 of a centime for 10 days) .